Optimal outcome measures for assessing exercise and rehabilitation approaches in chemotherapy-induced peripheral-neurotoxicity: Systematic review and consensus expert opinion
Susanna B. Park(The University of Sydney), Ahmet Höke(Johns Hopkins University), Angelo Schenone(University of Genoa), Grace Kanzawa-Lee(University of Michigan), Paola Alberti(University of Milano-Bicocca), Stefano Tamburin(University of Verona), Andreas A. Argyriou(Agios Andreas Hospital), Elisa Mantovani(University of Verona), Guido Cavaletti(Bellvitge University Hospital), Ian R. Kleckner(University of Maryland, College Park), Maryam B. Lustberg(Yale Cancer Center), Roser Velasco(Universitat Autònoma de Barcelona), Susan G. Dorsey(University of Maryland, Baltimore), Mehrnaz Hamedani(University of Genoa)
Cited by 25
Related Papers
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2014|1.2k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
|Journal of Clinical Oncology|2020|1.1k
Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue
|JAMA Oncology|2017|913
Differences between human and mouse embryonic stem cells
|Developmental Biology|2004|715
Schwann Cells Express Motor and Sensory Phenotypes That Regulate Axon Regeneration
|Journal of Neuroscience|2006|426